GENUITI Trademark

Trademark Overview

On Wednesday, May 22, 2024, a trademark application was filed for GENUITI with the United States Patent and Trademark Office. The USPTO has given the GENUITI trademark a serial number of 98562943. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Sunday, December 15, 2024. This trademark is owned by GENUITI THERAPEUTICS, INC.. The GENUITI trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

therapeutic pharmaceuticals for the treatment of obesity and metabolic diseases, eye diseases, mitochondrial diseases, pulmonary hypertension, metabolic syndromes; pharmaceutical products for the treatment of obesity and metabolic diseases, eye diseases, mitochondrial diseases, pulmonary hypertension, metabolic syndromes; pharmaceutical preparations for the treatment of obesity and metabolic diseases, eye diseases, mitochondrial diseases, pulmonary hypertension, metabolic syndromes; pharmaceuticals comprising small molecules for the treatment of obesity and metabolic diseases, eye diseases, mitochondrial diseases, pulmonary hypertension, metabolic syndromes

scientific research for medical purposes in the fields of obesity and metabolic diseases, eye diseases, mitochondrial diseases, pulmonary hypertension, metabolic syndromes; research and development of therapeutics for the treatment of obesity and metabolic diseases, eye diseases, mitochondrial diseases, pulmonary hypertension, metabolic syndromes; research and development in the field of small molecule drug discovery; medical and scientific research in the field of obesity and metabolic diseases, eye diseases, mitochondrial diseases, pulmonary hypertension, metabolic syndromes; pharmaceutical products development in the field of obesity and metabolic diseases, eye diseases, mitochondrial diseases, pulmonary hypertension, metabolic syndromes; drug discovery services in the field of obesity and metabolic diseases, eye diseases, mitochondrial diseases, pulmonary hypertension, metabolic syndromes; pharmaceutical research and development services in the field of obesity and metabolic diseas...
genuiti

General Information

Serial Number98562943
Word MarkGENUITI
Filing DateWednesday, May 22, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateSunday, December 15, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and Servicestherapeutic pharmaceuticals for the treatment of obesity and metabolic diseases, eye diseases, mitochondrial diseases, pulmonary hypertension, metabolic syndromes; pharmaceutical products for the treatment of obesity and metabolic diseases, eye diseases, mitochondrial diseases, pulmonary hypertension, metabolic syndromes; pharmaceutical preparations for the treatment of obesity and metabolic diseases, eye diseases, mitochondrial diseases, pulmonary hypertension, metabolic syndromes; pharmaceuticals comprising small molecules for the treatment of obesity and metabolic diseases, eye diseases, mitochondrial diseases, pulmonary hypertension, metabolic syndromes
Goods and Servicesscientific research for medical purposes in the fields of obesity and metabolic diseases, eye diseases, mitochondrial diseases, pulmonary hypertension, metabolic syndromes; research and development of therapeutics for the treatment of obesity and metabolic diseases, eye diseases, mitochondrial diseases, pulmonary hypertension, metabolic syndromes; research and development in the field of small molecule drug discovery; medical and scientific research in the field of obesity and metabolic diseases, eye diseases, mitochondrial diseases, pulmonary hypertension, metabolic syndromes; pharmaceutical products development in the field of obesity and metabolic diseases, eye diseases, mitochondrial diseases, pulmonary hypertension, metabolic syndromes; drug discovery services in the field of obesity and metabolic diseases, eye diseases, mitochondrial diseases, pulmonary hypertension, metabolic syndromes; pharmaceutical research and development services in the field of obesity and metabolic diseases, eye diseases, mitochondrial diseases, pulmonary hypertension, metabolic syndromes; research and development in the field of precision medicine

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, May 22, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, May 22, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGENUITI THERAPEUTICS, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLincoln, MA 01773

Trademark Events

Event DateEvent Description
Wednesday, May 22, 2024NEW APPLICATION ENTERED
Wednesday, November 27, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, December 5, 2024ASSIGNED TO EXAMINER
Sunday, December 15, 2024NON-FINAL ACTION WRITTEN
Sunday, December 15, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sunday, December 15, 2024NON-FINAL ACTION E-MAILED

Related Keywords

genuiti diseases metabolic obesity hypertension syndromes mitochondrial pulmonary research field treatment